Visual Acuity of Eyes with Early Persistent Retinal Fluid from Neovascular Age-Related Macular Degeneration in the VIEW Studies
To compare the effect of intravitreal aflibercept or ranibizumab drug type and frequency on visual acuity outcomes in eyes with neovascular age-related macular degeneration (NVAMD) and early persistent retinal fluid after 3 initial monthly injections.
Source: Ophthalmology - Category: Opthalmology Authors: Glenn J. Jaffe, Peter K. Kaiser, Desmond Thompson, Andrea Gibson, Namrata Saroj, Robert Vitti, Alyson J. Berliner, Jeffrey S. Heier Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Eyes | Lucentis | Opthalmology | Ranibizumab Injection | Study